Reimagining Medication Adherence: A Novel Holistic Model for Hypertension Therapy

References

• Ibrahim KM, Schommer JC, Morisky DE, Rodriguez R, Gaither C, Snyder M. The association between medication experiences and beliefs and low medication adherence in patients with chronic disease from two different societies: the USA and the Sultanate of Oman. Pharmacy. 2021;9(1):31. doi:10.3390/pharmacy9010031
   Web of Science ®Google Scholar
• World Health Organization. Failure to Take Prescribed Medicine for Chronic Diseases is a Massive. World-Wide Problem; 2003.
   Google Scholar
• Kronish IM, Ye S. Adherence to cardiovascular medications: lessons learned and future directions. Prog Cardiovasc Dis. 2013;55(6):590–600. doi:10.1016/j.pcad.2013.02.001
   PubMed Web of Science ®Google Scholar
• Iuga AO, McGuire MJ. Adherence and health care costs. Risk Manag Healthc Policy. 2014;7:35–44. doi:10.2147/RMHP.S19801
   PubMedGoogle Scholar
• Raghupathi W, Raghupathi V. An empirical study of chronic diseases in the United States: a visual analytics approach. Int J Environ Res Public Health. 2018;15(3). doi:10.3390/ijerph15030431
   PubMed Web of Science ®Google Scholar
• Ebrahim S. Chronic diseases and calls to action. Int J Epidemiol. 2008;37(2):225–230. doi:10.1093/ije/dyn016
   PubMed Web of Science ®Google Scholar
• Elston Lafata J, Nguyen B, Staresinic C, Johnson M, Gratie D, Muluneh B. Interpersonal communication-, education- and counselling-based interventions to support adherence to oral anticancer therapy: a systematic review. J Oncol Pharm Pract. 2023;29(2):358–369. doi:10.1177/10781552211073576
   PubMedGoogle Scholar
• Mahfoud F, Kieble M, Enners S, et al. Use of fixed-dose combination antihypertensives in Germany between 2016 and 2020: an example of guideline inertia. Clin Res Cardiol. 2023;112(2):197–202. doi:10.1007/s00392-022-01993-5
   PubMed Web of Science ®Google Scholar
• Kardas P, Lewek P, Matyjaszczyk M. Determinants of patient adherence: a review of systematic reviews. Front Pharmacol. 2013;4:91. doi:10.3389/fphar.2013.00091
   PubMed Web of Science ®Google Scholar
• Quaschning K, Koerner M, Wirtz MA. Analyzing the effects of barriers to and facilitators of medication adherence among patients with cardiometabolic diseases: a structural equation modeling approach. BMC Health Serv Res. 2022;22(1):588. doi:10.1186/s12913-022-07987-3
   PubMed Web of Science ®Google Scholar
• Rivis A, Sheeran P. Social influences and the theory of planned behaviour: evidence for a direct relationship between prototypes and young people’s exercise behaviour. Psychol Health. 2003;18(5):567–583. doi:10.1080/0887044032000069883
   Web of Science ®Google Scholar
• Schmieder RE, Högerl K, Jung S, Bramlage P, Veelken R, Ott C. Patient preference for therapies in hypertension: a cross-sectional survey of German patients. Clin Res Cardiol. 2019;108(12):1331–1342. doi:10.1007/s00392-019-01468-0
   PubMed Web of Science ®Google Scholar
• Prigge J-K, Dietz B, Homburg C, Hoyer WD, Burton JL. Patient empowerment: a cross-disease exploration of antecedents and consequences. Int J Res Mark. 2015;32(4):375–386. doi:10.1016/j.ijresmar.2015.05.009
   Web of Science ®Google Scholar
• Voehler D, Neumann PJ, Ollendorf DA. Patient and caregiver views on measures of the value of health interventions. Patient Preference Adherence. 2022;16:3383–3392. doi:10.2147/PPA.S390227
   PubMed Web of Science ®Google Scholar
• Ruksakulpiwat S, Benjasirisan C, Ding K, et al. Utilizing social determinants of health model to understand barriers to medication adherence in patients with ischemic stroke: a systematic review. Patient Preference Adherence. 2023;17:2161–2174. doi:10.2147/PPA.S420059
   PubMed Web of Science ®Google Scholar
• Sawaengsri N, Maneesriwongul W, Schorr EN, Wangpitipanit S. Effects of telephone-based brief motivational interviewing on self-management, medication adherence, and glycemic control in patients with uncontrolled type 2 diabetes mellitus in a Rural Community in Thailand. Patient Preference Adherence. 2023;17:2085–2096. doi:10.2147/PPA.S418514
   PubMed Web of Science ®Google Scholar
• Naidu V, Ganeshamoorthy A, Allwin C. The mediating effect of self-efficacy on the relationship between medication literacy and medication adherence among patients with Type 2 diabetes letter. Patient Preference Adherence. 2023;17:1907–1908. doi:10.2147/PPA.S432752
   PubMed Web of Science ®Google Scholar
• Smith SG, Green SMC, Ellison R, et al. Refining and optimising a behavioural intervention to support endocrine therapy adherence (ROSETA) in UK women with breast cancer: protocol for a pilot fractional factorial trial. BMJ Open. 2023;13(2):e069971. doi:10.1136/bmjopen-2022-069971
   PubMed Web of Science ®Google Scholar
• Garbrah BG, Abebrese J, Owusu-Marfo J. Factors associated with tuberculosis treatment adherence among tuberculosis patients in the Kumasi metropolis in the Ashanti Region of Ghana; A cross-sectional study. J Public Health. 2023;1–12. doi:10.1007/s10389-023-02002-3
   PubMedGoogle Scholar
• Dima AL, Allemann SS, Dunbar-Jacob J, Hughes DA, Vrijens B, Wilson IB. Methodological considerations on estimating medication adherence from self-report, electronic monitoring and electronic healthcare databases using the TEOS framework. Br J Clin Pharmacol. 2023;89(7):1918–1927. doi:10.1111/bcp.15375
   PubMed Web of Science ®Google Scholar
• Bergner N, Falk T, Heinrich D, Hölzing D. The effects of DTCA on patient compliance. Int J Pharm Healthc Mark. 2013;7(4):391–409. doi:10.1108/IJPHM-05-2013-0031
   Google Scholar
• Hair JF, Hult GTM, Ringle CM, Sarstedt M. A Primer on Partial Least Squares Structural Equation Modeling (PLS-SEM). 3rd ed. Los Angeles: SAGE; 2022.
   Google Scholar
• Wolf-Maier K, Cooper RS, Kramer H, et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension. 2004;43(1):10–17. doi:10.1161/01.HYP.0000103630.72812.10
   PubMed Web of Science ®Google Scholar
• Hansson L, Lloyd A, Anderson P, Kopp Z. Excess morbidity and cost of failure to achieve targets for blood pressure control in Europe. Blood Press. 2002;11(1):35–45. doi:10.1080/080370502753543945
   PubMed Web of Science ®Google Scholar
• Mahfoud F, Schmieder RE, Azizi M, et al. Proceedings from the 2nd European Clinical Consensus Conference for device-based therapies for hypertension: state of the art and considerations for the future. Eur Heart J. 2017;38(44):3272–3281. doi:10.1093/eurheartj/ehx215
   PubMed Web of Science ®Google Scholar
• Fishbein M, Ajzen I. Belief, attitude, intention and behaviour: an introduction to theory and research. Reading; 1975.
   Google Scholar
• Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Processes. 1991;50(2):179–211. doi:10.1016/0749-5978(91)90020-T
   Web of Science ®Google Scholar
• Guo R, Berkshire SD, Fulton LV, Hermanson PM. Predicting intention to use evidence-based management among U.S. healthcare administrators: application of the theory of planned behavior and structural equation modeling. Int J Healthc Manag. 2019;12(1):25–32. doi:10.1080/20479700.2017.1336856
   Web of Science ®Google Scholar
• Hagger MS, Hamilton K. Effects of socio-structural variables in the theory of planned behavior: a mediation model in multiple samples and behaviors. Psychol Health. 2021;36(3):307–333. doi:10.1080/08870446.2020.1784420
   PubMed Web of Science ®Google Scholar
• Horne J, Madill J, Gilliland J. Incorporating the “Theory of Planned Behavior” into personalized healthcare behavior change research: a call to action. Pers Med. 2017;14(6):521–529. doi:10.2217/pme-2017-0038
   PubMed Web of Science ®Google Scholar
• Al-Noumani H, Wu JR, Barksdale D, Sherwood G, AlKhasawneh E, Knafl G, Health beliefs and medication adherence in patients with hypertension: a systematic review of quantitative studies. Patient Educ Couns. 2019;1026:1045–1056. doi:10.1016/j.pec.2019.02.022
   PubMed Web of Science ®Google Scholar
• Shankar A, Conner M, Bodansky HJ. Can the theory of planned behaviour predict maintenance of a frequently repeated behaviour? Psychol Health Med. 2007;12(2):213–224. doi:10.1080/09540120500521327
   PubMedGoogle Scholar
• Harvey JN, Lawson VL. The importance of health belief models in determining self-care behaviour in diabetes. Diabet Med. 2009;26(1):5–13. doi:10.1111/j.1464-5491.2008.02628.x
   PubMed Web of Science ®Google Scholar
• King-Shier KM, Singh S, Khan NA, et al. Ethno-cultural considerations in cardiac patients’ medication adherence. Clin Nurs Res. 2017;26(5):576–591. doi:10.1177/1054773816646078
   PubMed Web of Science ®Google Scholar
• Pollack MF, Purayidathil FW, Bolge SC, Williams SA. Patient-reported tolerability issues with oral antidiabetic agents: associations with adherence; treatment satisfaction and health-related quality of life. Diabet Res Clin Pract. 2010;87(2):204–210. doi:10.1016/j.diabres.2009.11.023
   PubMed Web of Science ®Google Scholar
• Meesala A, Paul J. Service Quality, consumer satisfaction and loyalty in hospitals: thinking for the future. J Retailing Con Serv. 2018;40:261–269. doi:10.1016/j.jretconser.2016.10.011
   Web of Science ®Google Scholar
• Fornell C, Mithas S, Morgeson FV, Krishnan MS. Customer satisfaction and stock prices: high returns, low risk. J Mark. 2006;70(1):3–14. doi:10.1509/jmkg.2006.70.1.3
   Web of Science ®Google Scholar
• Schirmer N, Ringle CM, Gudergan SP, Feistel MSG. The link between customer satisfaction and loyalty: the moderating role of customer characteristics. J Strateg Mark. 2018;26(4):298–317. doi:10.1080/0965254X.2016.1240214
   Web of Science ®Google Scholar
• Mittal V, Ross WT, Baldasare PM. The asymmetric impact of negative and positive attribute-level performance on overall satisfaction and repurchase intentions. J Mark. 1998;62(1):33–47. doi:10.1177/002224299806200104
   Web of Science ®Google Scholar
• Bolton RN, Lemon KN. A dynamic model of customers’ usage of services: usage as an antecedent and consequence of satisfaction. J Mark Res. 1999;36(2):171–186. doi:10.1177/002224379903600203
   Web of Science ®Google Scholar
• Unger T, Borghi C, Charchar F, et al. 2020 International Society of Hypertension global hypertension practice guidelines. J Hypertens. 2020;38(6):982–1004. doi:10.1097/HJH.0000000000002453
   PubMed Web of Science ®Google Scholar
• Montes Cardona JA, Hincapié Erira DA, Nati-Castillo HA, Sánchez-Vallejo J, Izquierdo-Condoy JS. Characteristics of inhaler technique in COPD patients in a Specialized Center in Armenia, Colombia: a cross-sectional study. Patient Prefer Adherence. 2023;17:2025–2038. doi:10.2147/PPA.S417375
   PubMed Web of Science ®Google Scholar
• Psarou A, Cooper H, Wilding JPH. Patients’ perspectives of oral and injectable Type 2 diabetes medicines, their body weight and medicine-taking behavior in the UK: a systematic review and meta-ethnography. Diabetes Ther. 2018;9(5):1791–1810. doi:10.1007/s13300-018-0490-5
   PubMed Web of Science ®Google Scholar
• Hausman A. Modelling the patient-physician service encounter: improving patient outcomes. J Acad Marking Sci. 2004;32(4):403–417. doi:10.1177/0092070304265627
   Web of Science ®Google Scholar
• Schoenthaler A, Cuffee Y. A systematic review of interventions to improve adherence to diabetes medications within the patient-practitioner interaction. J Clin Outcomes Manag. 2013;20(11):494–506.
   Google Scholar
• Morgado MP, Morgado SR, Mendes LC, Pereira LJ, Castelo-Branco M. Pharmacist interventions to enhance blood pressure control and adherence to antihypertensive therapy: review and meta-analysis. Am J Health Syst Pharm. 2011;68(3):241–253. doi:10.2146/ajhp090656
   PubMed Web of Science ®Google Scholar
• Stewart K, George J, Mc Namara KP, et al. A multifaceted pharmacist intervention to improve antihypertensive adherence: a cluster-randomized, controlled trial (HAPPy trial). J Clin Pharm Ther. 2014;39(5):527–534. doi:10.1111/jcpt.12185
   PubMed Web of Science ®Google Scholar
• Connolly FR, Aitken LM, Tower M. An integrative review of self-efficacy and patient recovery post acute injury. J Adv Nurs. 2014;70(4):714–728. doi:10.1111/jan.12237
   PubMed Web of Science ®Google Scholar
• Singh J, Cuttler L, Silvers JB. Toward understanding consumers’ role in medical decisions for emerging treatments: issues, framework and hypotheses. J Bus Res. 2004;57:1054–1065.
   Web of Science ®Google Scholar
• Jank S, Bertsche T, Schellberg D, Herzog W, Haefeli WE. The A14-scale: development and evaluation of a questionnaire for assessment of adherence and individual barriers. Pharm World Sci. 2009;31(4):426–431. doi:10.1007/s11096-009-9296-x
   PubMedGoogle Scholar
• Chatziefstratiou A, Giakoumidakis K, Fotos NV, Baltopoulos G, Brokalaki H. Scales for assessing medication adherence in patients with hypertension. Br J Nurs. 2019;28(21):1388–1392. doi:10.12968/bjon.2019.28.21.1388
   PubMedGoogle Scholar
• Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008;10(5):348–354. doi:10.1111/j.1751-7176.2008.07572.x
   PubMed Web of Science ®Google Scholar
• Ajzen I. Constructing a TpB questionnaire: conceptual and methodological considerations. Rev version; 2006. Available from: https://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=0574b20bd58130dd5a961f1a2db10fd1fcbae95d. Accessed February 23, 2023.
   Google Scholar
• Johnson MD, Gustafsson A, Andreassen TW, Lervik L, Cha J. The evolution and future of national customer satisfaction index models. J Econ Psychol. 2001;22(2):217–245. doi:10.1016/S0167-4870(01)00030-7
   Web of Science ®Google Scholar
• Ahlén GC, Mattsson B, Gunnarsson RK. Physician patient questionnaire to assess physician patient agreement at the consultation. Fam Pract. 2007;24(5):498–503. doi:10.1093/fampra/cmm043
   PubMed Web of Science ®Google Scholar
• Landgraf R, Huber F, Bartel R. Patient Als Partner. Wiesbaden; 2006.
   Google Scholar
• Diamantopoulos A. The error term in formative measurement models: interpretation and modeling implications. J Modell Manag. 2006;1(1):7–17. doi:10.1108/17465660610667775
   Google Scholar
• Ringle CM, Sarstedt M, Straub D. Editor’s comments: a critical look at the use of PLS-SEM in “MIS quarterly”. MIS Q. 2012;36(1):iii–xiv. doi:10.2307/41410402
   Web of Science ®Google Scholar
• Becker J-M, Klein K, Wetzels M. Hierarchical latent variable models in PLS-SEM: guidelines for using reflective-formative type models. Long Range Plann. 2012;45(5–6):359–394. doi:10.1016/j.lrp.2012.10.001
   Web of Science ®Google Scholar
• Jarvis CB, MacKenzie SB, Podsakoff PM. A critical review of construct indicators and measurement model misspecification in marketing and consumer research. J Consum Res. 2003;30(2):199–218. doi:10.1086/376806
   Web of Science ®Google Scholar
• Bagozzi RP, Heatherton TF. A general approach to representing multifaceted personality constructs: application to state self-esteem. Struct Equ Model Multidiscip J. 1994;1(1):35–67. doi:10.1080/10705519409539961
   Web of Science ®Google Scholar
• Ajzen I. Constructing a Theory of Planned Behavior Questionnaire; 2006.
   Google Scholar
• Lerner SF, Park KH, Hubatsch DA, Erichev V, Paczka JA, Roberts TV. Efficacy and tolerability of travoprost 0.004%/timolol 0.5% fixed-dose combination for the treatment of primary open-angle glaucoma or ocular hypertension inadequately controlled with beta-blocker monotherapy. J Ophthalmol. 2017;2017:1917570. doi:10.1155/2017/1917570
   PubMed Web of Science ®Google Scholar
• Goyal J, Khan ZY, Upadhyaya P, Goyal B, Jain S. Comparative study of high dose mono-therapy of amlodipine or telmisartan, and their low dose combination in mild to moderate hypertension. J Clin Diagn Res. 2014;8(6):HC08–HC11. doi:10.7860/JCDR/2014/9352.4500
   PubMedGoogle Scholar
• Corrao G, Parodi A, Zambon A, et al. Reduced discontinuation of antihypertensive treatment by two-drug combination as first step. Evidence from daily life practice. J Hypertens. 2010;28(7):1584–1590. doi:10.1097/HJH.0b013e328339f9fa
   PubMed Web of Science ®Google Scholar
• Legate AE, Ringle CM, Hair JF. PLS‐SEM: a method demonstration in the R statistical environment. Hum Resour Dev Q. 2023. doi:10.1002/hrdq.21517
   Web of Science ®Google Scholar
• Ringle CM, Wende S, Becker J-M. Smart PLS 4. Bönningstedt: SmartPLS; 2023.
   Google Scholar
• Hair J, Sarstedt M, Ringle CM, Gudergan SP. Advanced Issues in Partial Least Squares Structural Equation Modeling. Thousand Oaks: SAGE Publications, Incorporated; 2018.
   Google Scholar
• Cohen J. A power primer. Psychol Bull. 1992;112(1):155–159. doi:10.1037//0033-2909.112.1.155
   PubMed Web of Science ®Google Scholar
• Rigdon EE, Sarstedt M, Ringle CM. On comparing results from CB-SEM and PLS-SEM: five perspectives and five recommendations. MAR. 2017;39(3):4–16. doi:10.15358/0344-1369-2017-3-4
   Google Scholar
• Roemer E, Schuberth F, Henseler J. HTMT2–an improved criterion for assessing discriminant validity in structural equation modeling. IMDS. 2021;121(12):2637–2650. doi:10.1108/IMDS-02-2021-0082
   Google Scholar
• Gudergan SP, Ringle CM, Wende S, Will A. Confirmatory tetrad analysis in PLS path modeling. J Bus Res. 2008;61(12):1238–1249. doi:10.1016/j.jbusres.2008.01.012
   Web of Science ®Google Scholar
• Henseler J, Ringle CM, Sarstedt M. A new criterion for assessing discriminant validity in variance-based structural equation modeling. J Acad Marking Sci. 2015;43(1):115–135. doi:10.1007/s11747-014-0403-8
   Web of Science ®Google Scholar
• Hair JF, Risher JJ, Sarstedt M, Ringle CM. When to use and how to report the results of PLS-SEM. EBR. 2019;31(1):2–24. doi:10.1108/EBR-11-2018-0203
   Web of Science ®Google Scholar
• Hu L, Bentler PM. Fit indices in covariance structure modeling: sensitivity to underparameterized model misspecification. Psychol Methods. 1998;3(4):424–453. doi:10.1037/1082-989X.3.4.424
   Web of Science ®Google Scholar
• Saarti S, Hajj A, Karam L, et al. Association between adherence, treatment satisfaction and illness perception in hypertensive patients. J Hum Hypertens. 2016;30(5):341–345. doi:10.1038/jhh.2015.86
   PubMed Web of Science ®Google Scholar
• Jneid S, Jabbour H, Hajj A, et al. Quality of life and its association with treatment satisfaction, adherence to medication, and trust in physician among patients with hypertension: a cross-sectional designed study. J Cardiovasc Pharmacol Ther. 2018;23(6):532–542. doi:10.1177/1074248418784292
   PubMed Web of Science ®Google Scholar
• Tilea I, Petra D, Voidazan S, Ardeleanu E, Varga A. Treatment adherence among adult hypertensive patients: a cross-sectional retrospective study in primary care in Romania. Patient Preference Adherence. 2018;12:625–635. doi:10.2147/PPA.S162965
   PubMed Web of Science ®Google Scholar
• Nabi H, Vahtera J, Singh-Manoux A, et al. Do psychological attributes matter for adherence to antihypertensive medication? The Finnish public sector cohort study. J Hypertens. 2008;26(11):2236–2243. doi:10.1097/HJH.0b013e32830dfe5f
   PubMed Web of Science ®Google Scholar
• Saleem F, Hassali M, Shafie A, Atif M. Drug attitude and adherence: a qualitative insight of patients with hypertension. J Young Pharm. 2012;4(2):101–107. doi:10.4103/0975-1483.96624
   PubMedGoogle Scholar
• Stanton AL. Determinants of adherence to medical regimens by hypertensive patients. J Behav Med. 1987;10(4):377–394. doi:10.1007/BF00846477
   PubMed Web of Science ®Google Scholar
• Zugelj U, Zupancic M, Komidar L, Kenda R, Varda NM, Gregoric A. Self-reported adherence behavior in adolescent hypertensive patients: the role of illness representations and personality. J Pediatr Psychol. 2010;35(9):1049–1060. doi:10.1093/jpepsy/jsq027
   PubMed Web of Science ®Google Scholar
• Hamrahian SM, Maarouf OH, Fülöp T. A critical review of medication adherence in hypertension: barriers and facilitators clinicians should consider. Patient Preference Adherence. 2022;16:2749–2757. doi:10.2147/PPA.S368784
   PubMed Web of Science ®Google Scholar
• Hawrilenko M, Gray TD, Córdova JV. The heart of change: acceptance and intimacy mediate treatment response in a brief couples intervention. J Fam Psychol. 2016;30(1):93–103. doi:10.1037/fam0000160
   PubMed Web of Science ®Google Scholar
• Du LP, Cheng ZW, Zhang YX, Li Y, Mei D. The impact of fixed-dose combination versus free-equivalent combination therapies on adherence for hypertension: a meta-analysis. J Clin Hypertens. 2018;20(5):902–907. doi:10.1111/jch.13272
   PubMed Web of Science ®Google Scholar
• Jones DE, Carson KA, Bleich SN, Cooper LA, Patient trust in physicians and adoption of lifestyle behaviors to control high blood pressure. Patient Educ Couns. 2012;891:57–62. doi:10.1016/j.pec.2012.06.003
   PubMed Web of Science ®Google Scholar
• Rivera MD, Johnson M, Choe HM, et al. Evaluation of a pharmacists’ Patient Care process approach for hypertension. Am J Prev Med. 2022;62(1):100–104. doi:10.1016/j.amepre.2021.06.012
   PubMed Web of Science ®Google Scholar
• Choe HM, Farris KB, Stevenson JG, et al. Patient-centered medical home: developing, expanding, and sustaining a role for pharmacists. Am J Health Syst Pharm. 2012;69(12):1063–1071. doi:10.2146/ajhp110470
   PubMed Web of Science ®Google Scholar
• Urick BY, Trygstad TK, Farley JF. Patient outcomes from implementing an enhanced services pharmacy network. J Am Pharm Assoc. 2020;60(6):843–852:843–852.e15. doi:10.1016/j.japh.2020.05.009
   Google Scholar
• Carter BL, Ardery G, Dawson JD, et al. Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med. 2009;169(21):1996–2002. doi:10.1001/archinternmed.2009.358
   PubMedGoogle Scholar
• Xu X, Guo T, Liu Z, et al. A systematic review of patient preferences, expectations, and values for the management and treatment of hypertension. Patient Preference Adherence. 2022;16:2867–2876. doi:10.2147/PPA.S388356
   PubMed Web of Science ®Google Scholar